Last reviewed · How we verify
NCT05899140: SoTiClin
Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
Phase 4 trial testing Clindamycin in Skin Infection in 100 participants. Currently enrolling.
29 March 2026
Quick facts
| Lead sponsor | Frieder Schaumburg |
|---|---|
| Phase | Phase 4 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 15 March 2024 |
| Primary completion | 29 March 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across Sierra Leone |
Drugs / interventions tested
- Clindamycin (clindamycin) — full drug profile →
- Standard of care
Conditions studied
- Skin Infection — all drugs for Skin Infection →
- Staphylococcal Infections — all drugs for Staphylococcal Infections →
- Staphylococcus Aureus Infection — all drugs for Staphylococcus Aureus Infection →
Sponsor
Frieder Schaumburg
Who can join
18 and older, any sex, with Skin Infection or Staphylococcal Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is an exploratory study to evaluate the effect of adjunctive clindamycin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus in patients from Sierra Leone. The study hypothesizes that clindamycin, when added to routine treatment, will lead to a more rapid clinical resolution and less frequent recurrences of infection.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05899140
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Clindamycin
Trials testing the same drug.
- NCT07267013 — Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulatio · Phase 2 · recruiting
- NCT06702345 — Clostridioides Difficile Controlled Human Infection Model · NA · not yet recruiting
- NCT06422221 — An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures · Phase 4 · not yet recruiting
- NCT06120140 — Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small · Phase 2 · recruiting
- NCT05846399 — CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE) · Phase 4 · recruiting
Other recruiting trials for Skin Infection
Currently open trials in the same condition.
- NCT04615065 — Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05899140 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Frieder Schaumburg
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05899140.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing